(Q48392631)

11 February 2018

title

Clinical trial of CPT-11 and VM-26/VP-16 for patients with recurrent malignant brain tumors. (English)

1 reference

11 February 2018

1

Lynn G Feun

1 reference

11 February 2018

author name string

Angela Marini

2

1 reference

11 February 2018

Howard Landy

3

1 reference

11 February 2018

Arnold Markoe

4

1 reference

11 February 2018

Deborah Heros

5

1 reference

11 February 2018

Carlos Robles

6

1 reference

11 February 2018

Cristina Herrera

7

1 reference

11 February 2018

Niramol Savaraj

8

1 reference

11 February 2018

publication date

19 October 2006

1 reference

11 February 2018

Journal of Neuro-Oncology

published in

1 reference

11 February 2018

volume

82

1 reference

11 February 2018

issue

2

1 reference

11 February 2018

page(s)

177-181

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1007/s11060-006-9261-7

exact match

0 references

cites work

Comparison of topoisomerase I and II expression in primary brain tumor and lung cancer

1 reference

12 December 2020

Etoposide (VP-16-213) in malignant brain tumors: a phase II study.

1 reference

12 December 2020

Proceedings: 4'-Demethyl-epipodophyllotoxin-beta-D-thenylidene-glucoside (PTG) in the treatment of malignant intracranial neoplasms

1 reference

12 December 2020

Treatment with oral etoposide for childhood recurrent ependymomas

1 reference

12 December 2020

Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma.

1 reference

12 December 2020

A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study.

1 reference

12 December 2020

Intra-arterial carboplatin and intravenous etoposide for the treatment of recurrent and progressive non-GBM gliomas.

1 reference

12 December 2020

Irinotecan treatment for recurrent malignant glioma using an every-3-week regimen

1 reference

12 December 2020

Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma

1 reference

12 December 2020

Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme

1 reference

12 December 2020

Carboplatin and teniposide concurrent with radiotherapy in patients with glioblastoma multiforme: a phase II study

1 reference

12 December 2020

Irinotecan therapy in adults with recurrent or progressive malignant glioma.

1 reference

12 December 2020

Phase I clinical and pharmacokinetic study of irinotecan in adults with recurrent malignant glioma

1 reference

12 December 2020

Preradiation chemotherapy with VM-26 and CCNU in patients with glioblastoma multiforme

1 reference

12 December 2020

Salvage chemotherapy with CPT-11 for recurrent glioblastoma multiforme

1 reference

12 December 2020

Two studies evaluating irinotecan treatment for recurrent malignant glioma using an every-3-week regimen

1 reference

12 December 2020

Second-line chemotherapy with the association of liposomal daunorubicin, carboplatin and etoposide in children with recurrent malignant brain tumors

1 reference

12 December 2020

Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.

1 reference

12 December 2020

Phase 1 trial of irinotecan plus BCNU in patients with progressive or recurrent malignant glioma

1 reference

12 December 2020

Iv methyl-CCNU, VM-26, and cranial irradiation in therapy for malignant brain tumors

1 reference

12 December 2020

Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study

1 reference

12 December 2020

VM-26 as a second drug in the treatment of brain gliomas

1 reference

12 December 2020

Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma

1 reference

12 December 2020

Phase II evaluation of topotecan for pediatric central nervous system tumors.

1 reference

12 December 2020

Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience

1 reference

12 December 2020

Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma

1 reference

12 December 2020

Treatment of newly diagnosed glioblastoma multiforme with carmustine, cisplatin and etoposide followed by radiotherapy. A phase II study

1 reference

12 December 2020

Phase 2 study of weekly irinotecan in adults with recurrent malignant glioma: final report of NABTT 97-11.

1 reference

12 December 2020

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

12 December 2020

Preirradiation ifosfamide, carboplatin, and etoposide for the treatment of anaplastic astrocytomas and glioblastoma multiforme: a phase II study.

1 reference

12 December 2020

10.1007/S11060-006-9261-7

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018